FY2026 EPS Estimates for Envista Lifted by Leerink Partnrs

Key Points

• Leerink Partners has raised its FY2026 earnings per share (EPS) estimate for Envista Holdings to $1.21, an increase from the previous estimate of $1.14.
• Envista's reported quarterly earnings of $0.26 EPS surpassed analysts' expectations of $0.24, with a year-over-year revenue increase of 7.7%.
• Currently, Envista has an average rating of "Hold" from analysts, with a consensus price target of $21.08.

Envista Holdings Corporation (NYSE:NVST - Free Report) - Equities researchers at Leerink Partnrs boosted their FY2026 earnings per share (EPS) estimates for Envista in a research note issued on Tuesday, October 14th. Leerink Partnrs analyst M. Cherny now anticipates that the company will post earnings of $1.21 per share for the year, up from their prior estimate of $1.14. The consensus estimate for Envista's current full-year earnings is $1.00 per share. Leerink Partnrs also issued estimates for Envista's FY2027 earnings at $1.45 EPS and FY2028 earnings at $1.63 EPS.

Envista (NYSE:NVST - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $0.26 EPS for the quarter, topping analysts' consensus estimates of $0.24 by $0.02. Envista had a return on equity of 4.84% and a net margin of 2.11%.The company had revenue of $682.10 million for the quarter, compared to analyst estimates of $638.21 million. During the same quarter in the previous year, the firm earned $0.11 earnings per share. The business's revenue was up 7.7% on a year-over-year basis. Envista has set its FY 2025 guidance at 1.050-1.15 EPS.

NVST has been the topic of several other research reports. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Envista in a research note on Wednesday, October 8th. Wall Street Zen lowered Envista from a "strong-buy" rating to a "buy" rating in a research note on Saturday, August 30th. Mizuho upped their price target on Envista from $15.00 to $18.00 and gave the company an "underperform" rating in a research note on Friday, August 1st. Morgan Stanley upped their price target on Envista from $16.00 to $17.00 and gave the company an "equal weight" rating in a research note on Friday, August 1st. Finally, UBS Group upped their price target on Envista from $18.00 to $22.00 and gave the company a "neutral" rating in a research note on Tuesday, July 29th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, ten have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $21.08.

Envista Trading Up 1.2%

Shares of NVST opened at $19.45 on Wednesday. The company has a quick ratio of 2.08, a current ratio of 2.44 and a debt-to-equity ratio of 0.46. Envista has a 12-month low of $14.22 and a 12-month high of $23.00. The firm has a market capitalization of $3.23 billion, a PE ratio of 60.77, a price-to-earnings-growth ratio of 1.03 and a beta of 1.01. The stock's fifty day simple moving average is $20.67 and its 200-day simple moving average is $18.99.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the company. Farther Finance Advisors LLC grew its holdings in shares of Envista by 317.6% during the third quarter. Farther Finance Advisors LLC now owns 1,349 shares of the company's stock worth $27,000 after buying an additional 1,026 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Envista by 73.1% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company's stock worth $44,000 after buying an additional 949 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Envista by 378.0% during the second quarter. EverSource Wealth Advisors LLC now owns 2,414 shares of the company's stock worth $47,000 after buying an additional 1,909 shares in the last quarter. GAMMA Investing LLC grew its holdings in shares of Envista by 34.3% during the third quarter. GAMMA Investing LLC now owns 2,498 shares of the company's stock worth $51,000 after buying an additional 638 shares in the last quarter. Finally, Parallel Advisors LLC grew its holdings in shares of Envista by 100.1% during the second quarter. Parallel Advisors LLC now owns 2,792 shares of the company's stock worth $55,000 after buying an additional 1,397 shares in the last quarter.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.